Alteration of the microRNA network during the progression of Alzheimer's disease

被引:390
|
作者
Lau, Pierre [1 ,2 ,3 ]
Bossers, Koen [4 ]
Janky, Rekin's [5 ]
Salta, Evgenia [1 ,2 ,3 ]
Frigerio, Carlo Sala [1 ,2 ,3 ]
Barbash, Shahar [6 ,7 ]
Rothman, Roy [6 ,7 ]
Sierksma, Annerieke S. R. [1 ,2 ,3 ]
Thathiah, Amantha [1 ,2 ,3 ]
Greenberg, David [6 ,7 ]
Papadopoulou, Aikaterini S. [1 ,2 ,3 ]
Achsel, Tilmann [1 ,2 ,3 ]
Ayoubi, Torik [1 ,2 ,3 ,8 ]
Soreq, Hermona [6 ,7 ]
Verhaagen, Joost [4 ]
Swaab, Dick F. [9 ]
Aerts, Stein [5 ]
De Strooper, Bart [1 ,2 ,3 ]
机构
[1] VIB Ctr Biol Dis, Louvain, Belgium
[2] Katholieke Univ Leuven Hosp, LIND, Ctr Human Genet, Louvain, Belgium
[3] Katholieke Univ Leuven, Louvain, Belgium
[4] Netherlands Inst Neurosci, Neurogenerat Grp, Amsterdam, Netherlands
[5] Catholic Univ Louvain, Ctr Human Genet, Lab Computat Biol, B-3000 Louvain, Belgium
[6] Silberman Inst Life Sci, Dept Biol Chem, Jerusalem, Israel
[7] Edmond & Lily Safra Ctr Brain Sci, Interdisciplinary Ctr Neural Computat, Jerusalem, Israel
[8] St James Sch Med, Bonaire, Dutch Caribbean, Netherlands
[9] Netherlands Inst Neurosci, Neuropsychiat Disorders Grp, Amsterdam, Netherlands
基金
欧洲研究理事会;
关键词
Alzheimer's disease; hippocampus; prefrontal cortex; microRNA; miR-132-3p; MESSENGER-RNA EXPRESSION; TRANSCRIPTION FACTORS; MIRNA; IDENTIFICATION; DYSREGULATION; CONTRIBUTES; SCLEROSIS; DEMENTIA; CLUSTER; NEURONS;
D O I
10.1002/emmm.201201974
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
An overview of miRNAs altered in Alzheimer's disease (AD) was established by profiling the hippocampus of a cohort of 41 late-onset AD (LOAD) patients and 23 controls, showing deregulation of 35 miRNAs. Profiling of miRNAs in the prefrontal cortex of a second independent cohort of 49 patients grouped by Braak stages revealed 41 deregulated miRNAs. We focused on miR-132-3p which is strongly altered in both brain areas. Downregulation of this miRNA occurs already at Braak stages III and IV, before loss of neuron-specific miRNAs. Next-generation sequencing confirmed a strong decrease of miR-132-3p and of three family-related miRNAs encoded by the same miRNA cluster on chromosome 17. Deregulation of miR-132-3p in AD brain appears to occur mainly in neurons displaying Tau hyper-phosphorylation. We provide evidence that miR-132-3p may contribute to disease progression through aberrant regulation of mRNA targets in the Tau network. The transcription factor (TF) FOXO1a appears to be a key target of miR-132-3p in this pathway.
引用
收藏
页码:1613 / 1634
页数:22
相关论文
共 50 条
  • [41] Metabolome in progression to Alzheimer's disease
    M Orešič
    T Hyötyläinen
    S-K Herukka
    M Sysi-Aho
    I Mattila
    T Seppänan-Laakso
    V Julkunen
    P V Gopalacharyulu
    M Hallikainen
    J Koikkalainen
    M Kivipelto
    S Helisalmi
    J Lötjönen
    H Soininen
    [J]. Translational Psychiatry, 2011, 1 : e57 - e57
  • [42] Predicting progression of Alzheimer's disease
    Rachelle S Doody
    Valory Pavlik
    Paul Massman
    Susan Rountree
    Eveleen Darby
    Wenyaw Chan
    [J]. Alzheimer's Research & Therapy, 2
  • [43] Predicting progression of Alzheimer's disease
    Doody, R
    Pavlik, V
    Massman, P
    Rountree, SS
    Darby, E
    Chan, W
    [J]. NEUROLOGY, 2006, 66 (05) : A347 - A347
  • [44] Progression of atrophy in Alzheimer's disease
    Killiany, Ronald
    [J]. LANCET NEUROLOGY, 2006, 5 (10): : 805 - 806
  • [45] Metabolome in progression to Alzheimer's disease
    Oresic, M.
    Hyotylainen, T.
    Herukka, S-K
    Sysi-Aho, M.
    Mattila, I.
    Seppanan-Laakso, T.
    Julkunen, V.
    Gopalacharyulu, P. V.
    Hallikainen, M.
    Koikkalainen, J.
    Kivipelto, M.
    Helisalmi, S.
    Lotjonen, J.
    Soininen, H.
    [J]. TRANSLATIONAL PSYCHIATRY, 2011, 1 : e57 - e57
  • [46] Slowing progression of Alzheimer's disease
    不详
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (02) : 185 - 185
  • [47] Slowing the progression of Alzheimer's disease
    Laffman, Elise
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (05) : 656 - 656
  • [48] Halting the progression of Alzheimer's disease
    Houlton, S
    [J]. MANUFACTURING CHEMIST, 2001, 72 (09): : 18 - 20
  • [49] Predicting progression of Alzheimer's disease
    Doody, Rachelle S.
    Pavlik, Valory
    Massman, Paul
    Rountree, Susan
    Darby, Eveleen
    Chan, Wenyaw
    [J]. ALZHEIMERS RESEARCH & THERAPY, 2010, 2 (01):
  • [50] A Tensorized Multitask Deep Learning Network for Progression Prediction of Alzheimer's Disease
    Tabarestani, Solale
    Eslami, Mohammad
    Cabrerizo, Mercedes
    Curiel, Rosie E.
    Barreto, Armando
    Rishe, Naphtali
    Vaillancourt, David
    DeKosky, Steven T.
    Loewenstein, David A.
    Duara, Ranjan
    Adjouadi, Malek
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2022, 14